Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Testing effectiveness (Phase 2)Active Not RecruitingNCT04739800What this trial is testingComparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic AgentsWho this might be right forFallopian Tube Mucinous AdenocarcinomaOvarian Seromucinous CarcinomaPlatinum-Refractory Fallopian Tube Carcinoma+47 more National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Study completedNCT00939809What this trial is testingA6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CarcinomaMalignant Ovarian Mixed Epithelial TumorOvarian Brenner Tumor+7 more Gynecologic Oncology Group 31
Very early researchStudy completedNCT02111941What this trial is testingVaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Mucinous Neoplasm+20 more Mayo Clinic 19
Early research (Phase 1)Study completedNCT00814086What this trial is testingCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forChemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more Gynecologic Oncology Group 23
Testing effectiveness (Phase 2)WithdrawnNCT06393751What this trial is testingTesting the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian CancerWho this might be right forPlatinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00993616What this trial is testingBelinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or CisplatinWho this might be right forBrenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+7 more National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT00059787What this trial is testingErlotinib Plus Carboplatin and Paclitaxel in Ovarian CarcinomaWho this might be right forBrenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+6 more National Cancer Institute (NCI) 56
Large-scale testing (Phase 3)Looking for participantsNCT04575935What this trial is testingMinimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE TrialWho this might be right forAdvanced Ovarian CarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Tumor+22 more M.D. Anderson Cancer Center 580
Testing effectiveness (Phase 2)Study completedNCT00003944What this trial is testingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer Fox Chase Cancer Center 3
Early research (Phase 1)Study completedNCT01489371What this trial is testingEGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Seromucinous Carcinoma+5 more Gynecologic Oncology Group 16
Testing effectiveness (Phase 2)Study completedNCT02122185What this trial is testingMetformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forBrenner TumorMalignant AscitesMalignant Pleural Effusion+25 more University of Chicago 111
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Large-scale testing (Phase 3)Looking for participantsNCT05281471What this trial is testingEfficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)Who this might be right forPlatinum-resistant Ovarian CancerPlatinum-refractory Ovarian CancerFallopian Tube Cancer+4 more Genelux Corporation 186
Testing effectiveness (Phase 2)Study completedNCT00888615What this trial is testingElesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+15 more GOG Foundation 58
Testing effectiveness (Phase 2)Study completedNCT03648489What this trial is testingDual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)Who this might be right forOvarian CancerOvarian NeoplasmsOvarian Carcinosarcoma+7 more Imperial College London 134
Testing effectiveness (Phase 2)Ended earlyNCT02059265What this trial is testingDasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal CancerWho this might be right forEndometrial Clear Cell AdenocarcinomaOvarian Clear Cell CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+3 more National Cancer Institute (NCI) 35
Large-scale testing (Phase 3)WithdrawnNCT01492920What this trial is testingAcetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing ChemotherapyWho this might be right forFatigueMalignant Ovarian Mixed Epithelial TumorNeuropathy+10 more Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00408590What this trial is testingRecombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal CancerWho this might be right forOvarian CancerPrimary Peritoneal Cavity Cancer Mayo Clinic 37
Early research (Phase 1)Ended earlyNCT03924245What this trial is testingOlaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersWho this might be right forFallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more Vanderbilt-Ingram Cancer Center 3